Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Good
|
New words:
aching, acute, Addiction, Alzheimer, ameliorating, amputation, analog, apparent, appealing, appendage, ARB, arena, aspirin, beneficiary, bind, biotechnical, book, branded, breath, broader, cardiomyopathy, catastrophic, catheter, centrifugation, CHAHINEKenneth, Chapter, characteristic, chemotherapeutic, chromatorgraphic, classic, classification, clearance, Cognetix, cognitive, Collagen, Colorado, Columbia, column, compliment, complimentary, constant, constipation, convenience, coordinating, coordination, cord, core, CSL, cutting, Dawn, debilitating, deferral, dementia, denominator, density, device, diabetic, diagnosed, died, displayed, distant, edema, Elan, embodying, emission, emitted, encapsulated, endure, epidemiologic, epilepsy, Eunoe, excruciatingly, explain, fluorescent, format, French, gabapentin, Gehrig, GlaxoSmithKline, glia, glial, GmbH, gram, guidance, GW, half, headcount, hemorrhage, ideal, immunodeficiency, impending, inflammatory, insult, intervention, intraarterial, intrathecal, intrathecally, inversely, invited, irrespective, issuer, itching, Juvantia, Kirk, language, leadership, lesser, lidocaine, Lidoderm, limb, Lou, malfunction, McGuire, Medtronic, Merck, modulate, monetary, month, morphine, Mounting, musculoskeletal, Nastech, NDA, neighboring, neural, neuralgia, neurodegeneration, neurodegenerative, neurologist, Neurontin, neuropathy, NeuroSearch, neurotherapeutic, nociceptive, numerator, onset, opioid, overstated, pace, packaged, Parkinsonian, patch, pathophysiology, PET, Pfizer, phantom, Pharma, pipeline, plasmid, PositionPhilip, positron, postdoctoral, predominantly, preparatory, prevalence, Prialt, Princeton, processed, prophylactic, rat, readily, readministered, reconciling, regularly, reorganization, repaid, resignation, restarted, restore, restoring, retirement, reversal, reverse, reversed, Rockefeller, Rule, run, satisfactory, Schwartz, sedation, sensation, settlement, sharply, shell, shut, signal, simultaneously, speed, spinal, stigma, strength, stroke, tackle, tactile, template, Title, tomography, Traditionally, tramadol, transiently, transmitting, tricyclic, Ultram, uncontrolled, underestimated, undergone, undiscounted, unpackaged, World, Yale, ziconotide, zoster
Removed:
active, Albert, approach, authored, award, Baylor, Boeke, bringing, carried, cellular, Center, characterization, civil, comprised, constructing, David, Diamond, disposal, drafting, Editor, editorial, efficiency, Endocrinology, enforce, essential, expert, feasibility, functioning, Gaucher, genetic, Gray, group, growing, growth, Haig, Howard, impractical, introduce, investigating, investigator, involving, Israel, Japanese, Jef, Jeffrey, Jichi, journal, Jr, Kan, Kay, Kazazian, Keiya, knowledge, lacking, Lasker, leading, Lucent, mammalian, mammary, manipulation, mark, Mead, medicine, mixed, noted, objective, occasionally, outlined, Ozawa, preliminary, professor, prominent, promoter, purified, purpose, recipient, reflected, rendered, replacing, repurchase, rose, Rosen, Russell, Seattle, Seymour, shorter, sickle, Stanford, stem, stop, thalassemia, Transfusion, Transkaryotic, Transplantation, variety, virology, whichever, yield
Filing tables
Filing exhibits
AVGN similar filings
Filing view
External links
Exhibit 32.1
CERTIFICATION
Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), Kenneth G. Chahine, Chief Executive Officer of Avigen, Inc. (the “Company”), and Thomas J. Paulson, Chief Financial Officer of the Company, each hereby certify that, to the best of his knowledge:
1. | The Company’s Annual Report on Form 10-K for the period ended December 31, 2003, and to which this Certification is attached as Exhibit 32.1 (the “Periodic Report”) fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act, and |
2. | The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
In Witness Whereof, the undersigned have set their hands hereto as of the 8th day of March, 2004.
/s/ KENNETH G. CHAHINE Kenneth G. Chahine Chief Executive Officer /s/ THOMAS J. PAULSON Thomas J. Paulson Chief Financial Officer |